Enzalutamide

Sort by
Enzalutamide-DCTI-C-260-Daicel
Sold out

Enzalutamide D6

  • CAT Number DCTI-A-260
  • CAS Number 1443331-94-9
  • Molecular Formula C21H10D6F4N4O2S
  • Molecular Weight 470.48

Enzalutamide Desfluoro N-Methyl impurity

  • CAT NUMBER DCTI-C-2027
  • CAS NUMBER NA
  • MOLECULAR FORMULA C22H20F3N5O2S
  • MOLECULAR WEIGHT 475.49

Enzalutamide Desfluoro N-Methyl Methylbenzoate impurity

  • CAT NUMBER DCTI-C-2028
  • CAS NUMBER NA
  • MOLECULAR FORMULA C22H19F3N4O3S
  • MOLECULAR WEIGHT 476.47

Enzalutamide Impurity A

  • CAT NUMBER DCTI-C-2259
  • CAS NUMBER 654-70-6
  • MOLECULAR FORMULA C8H5F3N2
  • MOLECULAR WEIGHT 186.14

Enzalutamide Impurity P

  • CAT Number DCTI-C-1759
  • CAS NUMBER 1289942-66-0
  • MOLECULAR FORMULA C12H15FN2O3
  • MOLECULAR WEIGHT 254.26

Enzalutamide methyl ester

  • CAT NUMBER DCTI-C-2815
  • CAS NUMBER 1802242-43-8
  • MOLECULAR FORMULA C21H15F4N3O3S
  • MOLECULAR WEIGHT 465.42

Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamate

  • CAT Number DCTI-C-1832
  • CAS Number 1487515-37-6
  • Molecular Formula C10H7F3N2O2
  • Molecular Weight 244
Enzalutamide-DCTI-C-1152-Daicel
Sold out

N-Desmethyl Enzalutamide

  • CAT Number DCTI-C-1152
  • CAS Number 1242137-16-1
  • Molecular Formula C20H14F4N4O2S
  • Molecular Weight 450.41

Oxo-Enzalutamide

  • CAT Number DCTI-C-1760
  • CAS NUMBER 1242137-18-3
  • MOLECULAR FORMULA C21H16F4N4O3
  • MOLECULAR WEIGHT 448.38
LOAD MORE
You're viewed all 18 products
References
FAQ's

Frequently Asked Questions

Enzalutamide impurities are monitored regularly during drug development, manufacturing, and post-marketing surveillance to ensure the quality and safety of the drug.

Enzalutamide impurities affect patient safety due to toxicity, reduced efficacy, and increased risk of side effects.

Purification techniques, such as recrystallization and chromatography, help reduce the level of impurities in Enzalutamide.

N-desmethyl Enzalutamide, a known metabolite of the drug, is an impurity of concern. It has been found to have anti-androgenic activity and could potentially reduce the efficacy of Enzalutamide.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart